Hyman

Rett Syndrome Research Trust's Genetic Medicines Summit Sets the Stage for Accelerated Therapeutic Development

Retrieved on: 
Wednesday, October 11, 2023
Office of Rare Diseases Research, Food, Doctor of Philosophy, Biomarker, National Center for Advancing Translational Sciences, RSRT, Critical Path Institute, RNA, Harvard University, MD, DNA, Therapy, Summit, Center for Biologics Evaluation and Research, MPH, Roger Hawkins (drummer), IND, MacNamara, JD, Biotechnology, P.C, Rare, United States Department of the Army, MECP2, EEG, FDA, Broad Institute, Hyman, MIT, RNA editing, Clinical trial, Wuhan Institute of Biological Products, Bangladesh Technical Education Board, Regulation of tobacco by the U.S. Food and Drug Administration, COA, Rett syndrome, Pharmaceutical industry, Medical imaging, Rett, Research

TRUMBULL, Conn., Oct. 11, 2023 /PRNewswire-PRWeb/ -- The Rett Syndrome Research Trust (RSRT) is delighted to announce the successful conclusion of the inaugural Rett Syndrome Genetic Medicines Summit, held September 13 – 15 in Boston, Massachusetts. This landmark event gathered distinguished scientists, clinicians, regulatory experts, and over 40 leading biopharma companies. The goal of the Summit was to foster dialogue among scientific, clinical, industry, and regulatory stakeholders to facilitate collaboration, identify best practices, and refine expectations to expedite pre-clinical and clinical development programs focused on genetic medicines for children and adults with Rett syndrome.

Key Points: 
  • The Rett Syndrome Research Trust (RSRT) is delighted to announce the successful conclusion of the inaugural Rett Syndrome Genetic Medicines Summit, held September 13 – 15 in Boston, Massachusetts.
  • TRUMBULL, Conn., Oct. 11, 2023 /PRNewswire-PRWeb/ -- The Rett Syndrome Research Trust (RSRT) is delighted to announce the successful conclusion of the inaugural Rett Syndrome Genetic Medicines Summit, held September 13 – 15 in Boston, Massachusetts.
  • RSRT's Rett Syndrome Genetic Medicines Summit underscores the organization's unwavering commitment to curing Rett syndrome.
  • RSRT remains steadfast in its mission to accelerate the development of genetic therapies and ultimately find a cure for Rett syndrome.

Ordr Appoints Cybersecurity Leader and Industry Expert Jim Hyman as CEO

Retrieved on: 
Wednesday, November 2, 2022
Zero, IOT, Growth, Board of directors, CEO, Acquisition, Bell–LaPadula model, Anomaly, Organization, Board, Time, IBM, Director, Risk, NAC, Map, Behavior, Hyman, Technology, VP, Compliance, Trusteer, Machine learning, Multimedia, Synack, Battery Ventures, Zscaler, OT, Management, Risk management, Online shopping, Northgate Capital, Ordre des Administrateurs Agréés du Québec

SANTA CLARA, Calif., Nov. 2, 2022 /PRNewswire/ -- Ordr, the leader in connected device security, announced today that Jim Hyman has been appointed Chief Executive Officer (CEO) and member of the company's Board of Directors. With more than 25 years of deep experience in cybersecurity and technology, and a proven record of scaling and operating companies for growth, Hyman will use his experience to continue building a world-class organization as the company enters a new phase of growth. Hyman was most recently Chief Operating Officer at Synack, VP Sales at Trusteer prior to its acquisition by IBM, and spent four years as the VP of Sales at Zscaler. Hyman succeeds Greg Murphy as CEO, who is leaving to pursue other interests, but will remain an advisor to the company.

Key Points: 
  • SANTA CLARA, Calif., Nov. 2, 2022 /PRNewswire/ -- Ordr , the leader in connected device security, announced today that Jim Hyman has been appointed Chief Executive Officer (CEO) and member of the company's Board of Directors.
  • Hyman succeeds Greg Murphy as CEO, who is leaving to pursue other interests, butwill remain an advisor to the company.
  • Former Synack COO joins Ordr to lead company through accelerating demand for connected device visibility and security.
  • "Jim's background in cybersecurity and his experience across sales, business development and operations make him the perfect leader to accelerate Ordr's growth.

WCG FDAnews Announces the 17th Annual FDA Inspections Summit, Nov. 16-18, 2022, Washington, DC

Retrieved on: 
Friday, October 14, 2022
Kang Yong-sop, Hyman, MacNamara, Clinical, Compliance, Hay, Regulatory affairs, CEO, Pharming, OPQ, Medical device, Alston & Bird, FDA, Alston, Document, Dietary supplement

FALLS CHURCH, Va. , Oct. 14, 2022  /PRNewswire-PRWeb/ -- 17th Annual FDA Inspections Summit **Presented by WCG FDAnews** Nov. 16-18, 2022 • Washington, DC https://wcg.swoogo.com/fda-inspections-summit-2022

Key Points: 
  • The 17th Annual FDA Inspections Summit has exactly what drug and device manufacturers, and clinical trial professionals need to successfully navigate inspections into 2023 and beyond.
  • Attendees can save up to $200 by registering by the early bird deadline of Oct. 21.
  • This year's summit features industry experts, including past and present FDA officials, will present and lead the hands-on sessions needed for inspection success.
  • An interactive inspection so attendees are ready for anything the next time the FDA shows up.

Dan Hyman Joins Lowers & Associates International as Industry Liaison Officer

Retrieved on: 
Tuesday, July 26, 2022
CEO, Government, Organization, Offshore Industry Liaison Committee, Hyman, Aviation, Air Line Pilots Association, International, Risk, Lower Mekong initiative, Industry, Private investigator, Risk management

PURCELLVILLE, Va., July 26, 2022 /PRNewswire-PRWeb/ -- Lowers & Associates International, the international risk mitigation and loss prevention company of Lowers Risk Group, announces the hiring of Dan Hyman to serve as Industry Liaison Officer. In this role, Hyman will leverage industry and military experience alongside his background in aviation and criminal justice.

Key Points: 
  • PURCELLVILLE, Va., July 26, 2022 /PRNewswire-PRWeb/ -- Lowers & Associates International, the international risk mitigation and loss prevention company of Lowers Risk Group, announces the hiring of Dan Hyman to serve as Industry Liaison Officer.
  • In this role, Hyman will leverage industry and military experience alongside his background in aviation and criminal justice.
  • At Lowers & Associates International, Hyman will lead the formation of relationships with industry and government and will spearhead training programs to improve client success.
  • Lowers & Associates International is a Lowers Risk Group company providing risk mitigation, loss prevention, and complex investigations and recovery solutions to the international insurance market and to organizations operating around the globe in high-risk, highly-regulated environments.

PREDICTIVEHIRE BECOMES SAPIA TO REFLECT THE IMPACT THEIR GAME CHANGING TECHNOLOGY IS HAVING ON THE HR SECTOR

Retrieved on: 
Tuesday, April 26, 2022
Virgin Media, Hyman, Research, NPS, Bias, Woodies, Industrial and organizational psychology, Organization, Qantas, SIOP, Efficiency, Human, Technology, Love, Natural language processing, Society, Society for Industrial and Organizational Psychology, Solution, Woolworth, Interview, AI, F1, Industrial, IP, WOLT, Phuthuma Nhleko

"From day one we have focussed on creating AI technology that elevates the human experience," said Sapia CEO Barb Hyman.

Key Points: 
  • "From day one we have focussed on creating AI technology that elevates the human experience," said Sapia CEO Barb Hyman.
  • That means that when you use Sapia the impact on hiring diversity is immediate."
  • "This is why iconic consumer brands like Qantas, WOLT, VirginMedia and O2 select our technology," said Hyman.
  • Hyman said she was personally proud of the impact they were having on hiring for diversity.

PREDICTIVEHIRE BECOMES SAPIA TO REFLECT THE IMPACT THEIR GAME CHANGING TECHNOLOGY IS HAVING ON THE HR SECTOR

Retrieved on: 
Tuesday, April 26, 2022
Virgin Media, Hyman, Research, NPS, Bias, Woodies, Industrial and organizational psychology, Organization, Qantas, SIOP, Efficiency, Human, Technology, Love, Natural language processing, Society, Society for Industrial and Organizational Psychology, Solution, Woolworth, Interview, AI, F1, Industrial, IP, WOLT, Phuthuma Nhleko

"From day one we have focussed on creating AI technology that elevates the human experience," said Sapia CEO Barb Hyman.

Key Points: 
  • "From day one we have focussed on creating AI technology that elevates the human experience," said Sapia CEO Barb Hyman.
  • That means that when you use Sapia the impact on hiring diversity is immediate."
  • "This is why iconic consumer brands like Qantas, WOLT, VirginMedia and O2 select our technology," said Hyman.
  • Hyman said she was personally proud of the impact they were having on hiring for diversity.

Judy Hyman's newly released "The Girl Who Ate All the Rice in China" is a heartfelt tale of a young girl's adoption from China.

Retrieved on: 
Tuesday, March 15, 2022
Apple, Hyman, ITunes, Time, Barnes, Family, Amazon (company), Christianity, Adoption, Toy, Noble

MEADVILLE, Pa., March 15, 2022 /PRNewswire-PRWeb/ -- "The Girl Who Ate All the Rice in China": a true tale of a family's love.

Key Points: 
  • MEADVILLE, Pa., March 15, 2022 /PRNewswire-PRWeb/ -- "The Girl Who Ate All the Rice in China": a true tale of a family's love.
  • "The Girl Who Ate All the Rice in China" is the creation of published author Judy Hyman, a dedicated wife and loving mother of six.
  • Published by Christian Faith Publishing, Judy Hyman's new book is an engaging tale of adoption and a little girl's hope.
  • For additional information or inquiries about "The Girl Who Ate All the Rice in China," contact the Christian Faith Publishing media department at 866-554-0919.

Agile Therapeutics Appoints Josephine Torrente to its Board of Directors

Retrieved on: 
Friday, October 8, 2021
Corporation, Freedom, Company, Hyman, Therapy, Levonorgestrel, COVID-19, A Call for Unity, GLOBE, Annual report, Temple University Beasley School of Law, Securities Exchange Act of 1934, Board, FDA, Parliamentary Information Technology Committee, U.S. Securities and Exchange Commission, Health, Nasdaq, University, Woman, Skin, Temple University School of Pharmacy, Wyeth, MacNamara, Securities Act of 1933, Case Western Reserve University, Birmingham, Science, Pharmaceutical industry

PRINCETON, N.J., Oct. 08, 2021 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a womens healthcare company, today announced that Josephine Torrente has been appointed to the Companys board of directors, as a Class II director, effective as of October 7, 2021.

Key Points: 
  • PRINCETON, N.J., Oct. 08, 2021 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a womens healthcare company, today announced that Josephine Torrente has been appointed to the Companys board of directors, as a Class II director, effective as of October 7, 2021.
  • Ms. Torrente will serve on Agiles Science and Technology Committee and Nominating and Corporate Governance Committee.
  • Josephine is a keen regulatory strategist with extensive experience guiding new drug therapies through the FDA approval process.
  • Agile Therapeutics is a women's healthcare company dedicated to fulfilling the unmet health needs of todays women.

Experienced Financial Restructuring and Transactional Insolvency Lawyer Frederick (Rick) Hyman Joins Crowell & Moring

Retrieved on: 
Wednesday, August 4, 2021
Debt, Finance, Money, Economy, United States bankruptcy law, Corporate finance, Bankruptcy, Crowell & Moring, Debtor-in-possession financing, Restructuring, Hyman, Moring

NEW YORK, Aug. 4, 2021 /PRNewswire/ --Crowell & Moring has expanded its Corporate Group in New York with the addition of partner Frederick "Rick" Hyman , a highly regarded financial restructuring and insolvency lawyer.

Key Points: 
  • NEW YORK, Aug. 4, 2021 /PRNewswire/ --Crowell & Moring has expanded its Corporate Group in New York with the addition of partner Frederick "Rick" Hyman , a highly regarded financial restructuring and insolvency lawyer.
  • Hyman represents lenders and other creditors in all aspects of bankruptcy, including negotiating restructuring support agreements and debtor-in-possession financing facilities.
  • Hyman joins the firm from Duane Morris, where he was a partner in the firm'sBusiness Reorganization and Financial Restructuring Practice Group.
  • "I am incredibly excited to join Crowell & Moring, especially considering the breadth of the firm's offerings to financial services clients," said Hyman.

Dr. Mark Hyman Joins Levels as Advisor

Retrieved on: 
Tuesday, May 18, 2021
Mark Hyman, David Perlmutter, Hyman, American writers, Physicians, Writers

b'NEW YORK, May 18, 2021 /PRNewswire/ -- Levels , the first biowearable system to give real-time biofeedback on nutrition and lifestyle, today announced that Dr. Mark Hyman has joined the company as an Adviso r .

Key Points: 
  • b'NEW YORK, May 18, 2021 /PRNewswire/ -- Levels , the first biowearable system to give real-time biofeedback on nutrition and lifestyle, today announced that Dr. Mark Hyman has joined the company as an Adviso r .
  • Dr. Hyman is an internationally recognized leader, speaker, educator, and advocate in the field of Functional Medicine.
  • Dr. Hyman joins current Levels Advisors including: Gerald Shulman, MD, PhD; Ben Bikman, PhD; Dom D\'Agostino, PhD; Sara Gottfried, MD; Molly Maloof, MD; and David Perlmutter, MD.\n"Dr. Mark Hyman is the preeminent pioneer in bringing the importance of metabolic health to the mainstream conversation and communicating how metabolism is the foundation of health.
  • Stable and healthy blood sugar levels are required for good health and longevity, and Levels is revolutionizing the ability of individuals to achieve this.